BML, Inc. (BMLKF)
24.10
0.00 (0.00%)
USD |
OTCM |
Feb 06, 16:00
BML EPS Diluted (Quarterly) : 0.4028 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Nxera Pharma Co., Ltd. | -0.1253 |
| PeptiDream Inc. | -0.0575 |
| Stemcell Holdings, Inc. | -- |
| Healios KK | 0.0331 |
| AnGes, Inc. | -0.0127 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 15.59M |
| Revenue (Quarterly) | 252.14M |
| Total Expenses (Quarterly) | 236.96M |
| Enterprise Value | 545.97M |
| Gross Profit Margin (Quarterly) | 32.78% |
| Profit Margin (Quarterly) | 6.18% |
| Earnings Yield | 5.47% |
| Operating Earnings Yield | 7.53% |
| Normalized Earnings Yield | 5.594 |